Prevalence of Human papillomavirus Types 6, 11, 16, 18, 31, and 33 in a Cohort of Greek Women

被引:19
|
作者
Panotopoulou, Efstathia
Tserkezoglou, Aliki
Kouvousi, Maria
Tsiaousi, Ioanna
Chatzieleftheriou, George
Daskalopoulou, Demitra
Magiakos, George
机构
[1] Reg Anticanc Oncol Hosp Athens St Savvas, Papanicolaou Res Ctr Oncol Expt Surg, Dept Virol, Athens 11522, Greece
[2] Reg Anticanc Oncol Hosp Athens St Savvas, Dept Gynecol, Athens, Greece
[3] Reg Anticanc Oncol Hosp Athens St Savvas, Dept Cytopathol, Athens, Greece
关键词
HPV; cervical cancer; cytological examination;
D O I
10.1002/jmv.21025
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To study HPV prevalence and HPV types 6, 11, 16, 18,31, and 33 distribution in cervical smears in a cohort of Greek women. One thousand six hundred thirty-six samples were cytologically evaluated and molecularly analyzed, by PCR based assay. Abnormal cytology was identified in 997 women and 75.4% of them were HPV DNA positive, while 639 had normal cytology and 24.6% were HPV DNA positive. HPV was detected in 62.9% of 256ASCUS smears, 89.3% of 516 LSIL, 86.7% of 60 HSIL and 47.3% of 165 with cervical carcinoma. Overall, HPV I I was the most common type (13.4%), followed by 18 (10.3%), 6 (7.2%), 16 (6.4%), 31 (3.4%) and 33 (3.4%). Multiple infections with two (11.3%) or more types, primarily 11 and 18 (4.8%), were also identified. Low-risk types 1 land 6 were common in ASCUS (36.6% and 26.4%, respectively), and high-risk types 16 and 18 in HSIL (42.3% and 30.8%, respectively) and in cancer (51.3% and 41%, respectively). Multiple infections were detected in 2.2% of normal and 31.7% of HSIL. HPV prevalence was 75.4% in abnormal and 24.6% in normal cervical smears. HPV 16 and 18 were the most common types in cancer. Single infection with type 11 and multiple infections with 11 and 18 were more frequent.
引用
收藏
页码:1898 / 1905
页数:8
相关论文
共 50 条
  • [1] Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
    Ji, Jia
    Sun, Hai-Kui
    Smith, Jennifer S.
    Wang, He
    Esser, Mark T.
    Hu, Shangying
    Pretorius, Robert G.
    Chen, Wen
    Belinson, Jerome L.
    Qiao, You-Lin
    BMC INFECTIOUS DISEASES, 2012, 12
  • [2] Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
    Jia Ji
    Hai-Kui Sun
    Jennifer S Smith
    He Wang
    Mark T Esser
    Shangying Hu
    Robert G Pretorius
    Wen Chen
    Jerome L Belinson
    You-Lin Qiao
    BMC Infectious Diseases, 12
  • [3] Incidence of human papillomavirus 6, 11, 16, 18 and 33 in normal oral mucosa of a Greek population
    Lambropoulos, AF
    Dimitrakopoulos, J
    Frangoulides, E
    Katopodi, R
    Kotsis, A
    Karakasis, D
    EUROPEAN JOURNAL OF ORAL SCIENCES, 1997, 105 (04) : 294 - 297
  • [4] Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types -6, -11, -16, -18, -31 and -33
    Mant, C
    Kell, B
    Best, JM
    Cason, J
    JOURNAL OF VIROLOGICAL METHODS, 1997, 66 (02) : 169 - 178
  • [5] Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia
    Newall, Anthony T.
    Brotherton, Julia M. L.
    Quinn, Helen E.
    McIntyre, Peter B.
    Backhouse, Josephine
    Gilbert, Lynn
    Esser, Mark T.
    Erick, Joanne
    Bryan, Janine
    Formica, Neil
    MacIntyre, C. Raina
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (11) : 1647 - 1655
  • [6] PREVALENCE OF HUMAN PAPILLOMAVIRUS TYPES 11, 16 AND 18 IN CERVICAL SWABS - A STUDY OF 1362 PREGNANT-WOMEN
    HORDING, U
    IVERSEN, AKN
    SEBBELOV, A
    BOCK, JE
    NORRILD, B
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1990, 35 (2-3): : 191 - 198
  • [7] Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial
    Six, Lucia
    Leodolter, Sepp
    Sings, Heather L.
    Barr, Eliav
    Haupt, Richard
    Joura, Elmar A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (21-22) : 666 - 671
  • [8] Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®)
    Siddiqui M.A.A.
    Perry C.M.
    Drugs, 2006, 66 (9) : 1263 - 1271
  • [9] Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine
    Monsonego, J.
    Cortes, J.
    Greppe, C.
    Hampl, M.
    Joura, E.
    Singer, A.
    VACCINE, 2010, 28 (51) : 8065 - 8072
  • [10] Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
    Serrano, Beatriz
    de Sanjose, Silvia
    Tous, Sara
    Quiros, Beatriz
    Munoz, Nubia
    Bosch, Xavier
    Alemany, Laia
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (13) : 1732 - 1741